TP53 and neoplasm: The combined treatment with RSV + CisPt on PE/CA-PJ49 tumor cells displayed a significant decrease of the TP53 expression, compared to FaDu tumor cells (p < 0.007, **) and to HaCaT cells (p < 0.004, **).